02 April 2022>: Articles
Infective Endocarditis Caused by in a Pediatric Patient: A Case Report and Literature Review
Rare disease
Abdulbary Ali Alhalimi E , Lateefah Talal AlShammari B , Ahmed Khalid Al-Qurayn E , Abdullatif Sami Al Rashed A*DOI: 10.12659/AJCR.935743
Am J Case Rep 2022; 23:e935743
Table 2. Summary of P. luteola cases associated with central venous line (1995–2015).
Author (yr) [ref] | Age/sex | Presentation | Associated condition/predisposing cause | Treatment | Duration of treatment | Outcome | Susceptible antibiotics | Resistant antibiotics |
---|---|---|---|---|---|---|---|---|
Our case | 9 years/Female | Infective endocarditis | Crohn’s disease, TPN, CVL | Piperacillin/tazobactam | 6 weeks | NED | Ceftazidime, piperacillin, tazobactam, Cefepime, Ciprofloxacin, Levofloxacin | NA |
Bayhan et al (2015) []3 | 72 months/Male | Bacteremia, pneumonia | Miller-Dieker syndrome, TPN, CVL | Imipenem | 34 days | NED | Amikacin, gentamicin, trimethoprim-sulfamethoxazole, and meropenem | Piperacillin/tazobactam, aztreonam, and colistin. In total, 15% and 85% of the isolates were resistant to ciprofloxacin and ceftazidime, respectively |
Bayhan et al (2015) []3 | 29 months/Male | Bacteremia | Tetralogy of Fallot, CVL | Imipenem | 7 days | NED | ||
Otto et al (2013) []2 | 63 years/Male | Bacteremia | CVL | Piperacillin | 7 days | NED | Amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, piperacillin, piperacillin-tazobactam, cephalotin, cefotaxim, ceftazidime, cefepime, aztreonam, imipenem, ertapenem, meropenem, gentamicin, amikacin, tobramycin, netilmicin, ciprofloxacin, levofloxacin, pefloxacin, rifampicin, fosfomycin, tigecycline, and colistin | NA |
Wen et al (2013) []1 | 14 years/Male | Sepsis | CVL | Ceftriaxone | 14 days | NED | NA | NA |
Casalta et al (2005) []18 | 53 years/Male | Infective endocarditis | Prosthetic valve | IV ticarcillin + clavulanic acid for 60 days and gentamicin for 15 days | 60 days | NED | Ampicillin, ureidopenicillin, third generation cephalosporins, fluoroquinolones, and aminoglycosides | NA |
Chihab et al (2004) []13 | 13 years/Male | Infective endocarditis | Rheumatic heart disease, Mitral valve replacement surgery | Ceftriaxone | 3 days | Death | Imipenem, colistin, ofloxacin, ciprofloxacin, cefotaxime, ceftazidime, ceftriaxone, and doxycycline | Amoxicillin, cephalothin, and trimethoprim-sulfamethoxazole |
Rahav et al (1995) []5 | 26 years/Female | Bacteremia | Trauma, splenectomy, Neurosurgery, CVL | Ciprofloxacin | 75 days | NED | Ampicillin (25%), Cefotaxime (100%), Ceftazidime (100%), Cefsulodin (75%), Mezlocillin (100%), Aztreonam (75%), Imipenem (100%), Tetracycline (25%), Cotrimoxazole (25%), Ciprofloxacin (100%), Gentamicin (100%), Amikacin (100%) | Ampicillin (75%), Cephalothin (100%), Cefuroxime (100%), Cefsulin (25%), Aztreonam (25%), Tetracycline (75%), Cotrimoxazole (75%) |
NED – no evidence of disease; NA – not available; TPN – total parenteral nutrition; CVL – central venous line. |